Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection

Journal of Virology

Volumn 85, Issue 16, 2011, Pages 8037-8045

  Rivas Aravena, Andrea ^a,b   Vallejos Vidal, Eva ^a   Martin, Marcelo Cortez San ^b   Reyes Lopez, Felipe ^b   Tello, Mario ^b   Mora, Patricia ^a   Sandino, Ana María ^a,b   Spencer, Eugenio ^b  

^a Research and Development Laboratories   (Chile)

^b UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR 1ALPHA; GENOMIC RNA; GUANOSINE; MESSENGER RNA; NUCLEOTIDE DERIVATIVE; RIBAVIRIN; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; FISH DISEASE; IC 50; IN VITRO STUDY; IN VIVO STUDY; INFECTIOUS SALMON ANEMIA VIRUS; MESSENGER RNA SYNTHESIS; MORTALITY; NONHUMAN; ORTHOMYXOVIRUS; ORTHOMYXOVIRUS INFECTION; POLYSOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS INHIBITION; RIBOSOME; SALMON; TREATMENT OUTCOME; VIRUS REPLICATION; VIRUS VIRULENCE;

INFECTIOUS SALMON ANEMIA VIRUS; ORTHOMYXOVIRIDAE; RNA VIRUSES; SALMO SALAR;

ANIMALS; ANTIVIRAL AGENTS; CELLS, CULTURED; FISH DISEASES; FLUORESCENT ANTIBODY TECHNIQUE; GUANOSINE; INHIBITORY CONCENTRATION 50; ISAVIRUS; ORTHOMYXOVIRIDAE INFECTIONS; POLYMERASE CHAIN REACTION; POLYRIBOSOMES; RIBAVIRIN; RNA, MESSENGER; RNA, VIRAL; SALMO SALAR; VIRUS REPLICATION;

EID: 79961184056     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00533-11     Document Type: Article

References (51)

1. Airaksinen, A., N. Pariente, L. Menéndez-Arias, and E. Domingo. 2003. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology 311:339-349.
2. Asche, F., H. Hansen, R. Tveteras, and S. Tveteras. 2009. The salmon disease crisis in Chile. Mar. Resour. Econ. 24:405-411.
3. Aspehaug, V., et al. 2004. Infectious salmon anemia virus (ISAV) genomic segment 3 encodes the viral nucleoprotein (NP), an RNA-binding protein with two monopartite nuclear localization signals (NLS). Virus Res. 106:51-60.
4. Barnes, E., et al. 2004. Impact of alpha interferon and ribavirin on the function of maturing dendritic cells. Antimicrob. Agents Chemother. 48: 3382-3389.
5. Bouchard, D., et al. 1999. Isolation of infectious salmon anemia virus (ISAV) from Atlantic salmon in New Brunswick, Canada. Dis. Aquat. Organ. 35: 131-137.
6. Bougie, I., and M. Bisaillon. 2004. The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme. J. Biol. Chem. 279:22124-22130.
7. Cassidy, L. F., and J. L. Patterson. 1989. Mechanism of La Crosse virus inhibition by ribavirin. Antimicrob. Agents Chemother. 33:2009-2011.
8. Clouthier, S. C., T. Rector, N. E. Brown, and E. D. Anderson. 2002. Genomic organization of infectious salmon anaemia virus. J. Gen. Virol. 83:421-428.
9. Cottet, L., et al. 2010. Bioinformatic analysis of the genome of infectious salmon anemia viruses associated with outbreaks of high mortality in Chile. J. Virol. 84:11916-11928.
10. Crotty, S., C. E. Cameron, and R. Andino. 2001. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. U. S. A. 98:6895-6900.
11. Crotty, S., et al. 2000. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat. Med. 6:1375-1379.
12. Dannevig, B. H., K. Falk, and E. Namork. 1995. Isolation of the causal virus of infectious salmon anaemia (ISA) in a long-term cell line from Atlantic salmon head kidney. J. Gen. Virol. 76:1353-1359.
13. Devold, M., B. Krossoy, V. Aspehaug, and A. Nylund. 2000. Use of RT-PCR for diagnosis of infectious salmon anaemia virus (ISAV) in carrier sea trout Salmo trutta after experimental infection. Dis. Aquat. Organ. 40:9-18.
14. DeWitte-Orr, S. J., and N. C. Bols. 2007. Cytopathic effects of chum salmon reovirus to salmonid epithelial, fibroblast and macrophage cell lines. Virus Res. 126:159-171.
15. Eriksson, B., et al. 1977. Inhibition of influenza virus RNA polymerase by ribavirin triphosphate. Antimicrob. Agents Chemother. 11:946-951.
16. Fernandez-Larsson, R., K. O'Connell, E. Koumans, and J. L. Patterson. 1989. Molecular analysis of the inhibitory effect of phosphorylated ribavirin on the vesicular stomatitis virus in vitro polymerase reaction. Antimicrob. Agents Chemother. 33:1668-1673.
17. Godoy, M. G., et al. 2008. First detection, isolation and molecular characterization of infectious salmon anaemia virus associated with clinical disease in farmed Atlantic salmon (Salmo salar) in Chile. BMC Vet. Res. 4:28.
18. Goic, B., et al. 2008. The nucleoprotein and the viral RNA of infectious salmon anemia virus (ISAV) are localized in the nucleolus of infected cells. Virology 379:55-63.
19. Goswami, B. B., E. Borek, O. K. Sharma, J. Fujitaki, and R. A. Smith. 1979. The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochem. Biophys. Res. Commun. 89:830-836.
20. Hellebo, A., U. Vilas, K. Falk, and R. Vlasak. 2004. Infectious salmon anemia virus specifically binds to and hydrolyzes 4-O-acetylated sialic acids. J. Virol. 78:3055-3062.
21. Hudson, J. B., E. A. Graham, and M. F. Simpson. 1988. The efficacy of amantadine and other antiviral compounds against two salmonid viruses in vitro. Antiviral Res. 9:379-385.
22. Jashés, M., G. M. M. López-Lastra, E. De Clercq, and A. Sandino. 1996. Inhibitors of infectious pancreatic necrosis virus (IPNV) replication. Antiviral Res. 29:309-312.
23. Jashes, M., G. Mlynarz, E. De Clercq, and A. M. Sandino. 2000. Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication. Antiviral Res. 45:9-17.
24. Krossoy, B., I. Hordvik, F. Nilsen, A. Nylund, and C. Endresen. 1999. The putative polymerase sequence of infectious salmon anemia virus suggests a new genus within the Orthomyxoviridae. J. Virol. 73:2136-2142.
25. Larsson, A., K. Stenberg, and B. Oberg. 1978. Reversible inhibition of cellular metabolism by ribavirin. Antimicrob. Agents Chemother. 13:154-158.
26. Leyssen, P., J. Balzarini, E. De Clercq, and J. Neyts. 2005. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. J. Virol. 79:1943-1947.
27. Lovely, J. E., et al. 1999. First identification of infectious salmon anaemia virus in North America with haemorrhagic kidney syndrome. Dis. Aquat. Organ. 35:145-148.
28. Luria, S., J. Darnell, D. Baltimore, and A. Campbell. 1978. General virology, 3rd ed. John Wiley & Sons, Inc., New York, NY.
29. Marroquí, L., A. Estepa, and L. Perez. 2007. Assessment of the inhibitory effect of ribavirin on the rainbow trout rhabdovirus VHSV by real-time reverse-transcription PCR. Vet. Microbiol. 122:52-60.
30. Merril, C. R., M. L. Dunau, and D. Goldman. 1981. A rapid sensitive silver stain for polypeptides in polyacrylamide gels. Anal. Biochem. 110:201-207.
31. Migus, D. O., and P. Dobos. 1980. Effect of ribavirin on the replication of infectious pancreatic necrosis virus in fish cell cultures. J. Gen. Virol. 47:47-57.
32. Mjaaland, S., E. Rimstad, K. Falk, and B. H. Dannevig. 1997. Genomic characterization of the virus causing infectious salmon anemia in Atlantic salmon (Salmo salar L.): an orthomyxo-like virus in a teleost. J. Virol. 71:7681-7686.
33. Oxford, J. S. 1975. Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (ribavirin). J. Gen. Virol. 28:409-414.
34. Page, T., and J. D. Connor. 1990. The metabolism of ribavirin in erythrocytes and nucleated cells. Int. J. Biochem. 22:379-383.
35. Prochaska, H. J., Y. Yeh, P. Baron, and B. Polsky. 1993. Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication. Proc. Natl. Acad. Sci. U. S. A. 90:3953-3957.
36. Rankin, J. T., Jr., S. B. Eppes, J. B. Antczak, and W. K. Joklik. 1989. Studies on the mechanism of the antiviral activity of ribavirin against reovirus. Virology 168:147-158.
37. Raynard, R. S., M. Snow, and D. W. Bruno. 2001. Experimental infection models and susceptibility of Atlantic salmon Salmo salar to a Scottish isolate of infectious salmon anaemia virus. Dis. Aquat. Organ. 47:169-174.
38. Ritchie, R. J., J. Heppell, M. B. Cook, S. Jones, and S. G. Griffiths. 2001. Identification and characterization of segments 3 and 4 of the ISAV genome. Virus Genes 22:289-297.
39. Rodger, H. D., T. Turnbull, F. Muir, S. Millar, and R. H. Richards. 1998. Infectious salmon anaemia (ISA) in the United Kingdom. Bull. Eur. Assoc. Fish Pathol. 18:115-116.
40. Severini, A., X. Y. Liu, J. S. Wilson, and D. L. Tyrrell. 1995. Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine. Antimicrob. Agents Chemother. 39:1430-1435.
41. Shigeta, S., K. K. T. Yokota, K. Nakamura, and E. De Clercq. 1988. Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitro. Antimicrob. Agents Chemother. 32:906-911.
42. Shigeta, S., et al. 1992. Antiviral activities of ribavirin, 5-ethynyl-1-beta-Dribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses. Antimicrob. Agents Chemother. 36:435-439.
43. Snow, M., et al. 2003. Isolation and characterisation of segment 1 of the infectious salmon anaemia virus genome. Virus Res. 92:99-105.
44. Streeter, D. G., et al. 1973. Mechanism of action of 1-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proc. Natl. Acad. Sci. U. S. A. 70:1174-1178.
45. Sun, Y., D.-H. Chung, Y.-K. Chu, C. B. Jonsson, and W. B. Parker. 2007. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase. Antimicrob. Agents Chemother. 51:84-88.
46. Toltzis, P., and A. S. Huang. 1986. Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells. Antimicrob. Agents Chemother. 29:1010-1016.
47. Vignuzzi, M., J. K. Stone, and R. Andino. 2005. Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications. Virus Res. 107:173-181.
48. Workenhe, S. T., M. J. Kibenge, T. Iwamoto, and F. S. Kibenge. 2008. Absolute quantitation of infectious salmon anaemia virus using different real-time reverse transcription PCR chemistries. J. Virol. Methods 154:128-134.
49. Wray, S. K., B. E. Gilbert, and V. Knight. 1985. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro. Antiviral Res. 5:39-48.
50. Wray, S. K., B. E. Gilbert, M. W. Noall, and V. Knight. 1985. Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis. Antiviral Res. 5:29-37.
51. Wray, S. K., R. H. Smith, B. E. Gilbert, and V. Knight. 1986. Effects of selenazofurin and ribavirin and their 5'-triphosphates on replicative functions of influenza A and B viruses. Antimicrob. Agents Chemother. 29:67-72.